Tag: software
-
Health Research Collaborative Adds Seven New Members
13 February 2014. Optum Labs, a partnership to increase sharing of solutions and data to improve health care, says seven more organizations from the private, university, and not-for-profit sectors became members of the collaboration. The new participants join current Optum Labs members Optum, a subsidiary of UnitedHealth Group, Mayo Clinic, and AARP. The Optum Labs…
-
Belgium-U.S. Consortium Developing Lung Image Technology
11 February 2014. A group of companies and universities in Belgium and the U.S. are collaborating on an advanced imaging technology to spot signs of lung transplant rejection earlier in a patient’s recovery. Fluidda nv in Kontich, Belgium is leading the collaboration, with additive manufacturing company Materialise in Leuven, Belgium, and universities in Belgium (University…
-
Sense of Touch Restored to Amputee’s Prosthetic Hand
5 February 2014. Biomedical engineers and computer scientists at Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland developed a sensory feedback system for an amputee’s prosthetic hand to control grasping and sense stiffness and shapes of objects. The findings of the Lifehand 2 team led by EPFL’s Silvestro Micera, with colleagues from other institutions in Europe,…
-
Telemedicine Found to Expand Care to Less Engaged Patients
4 February 2014. A study by Rand Corporation, a policy analysis organization, indicates people who use a service that makes possible medical help from a doctor over the telephone tend to be those without established health care relationships. The findings of Rand policy analysts Lori Uscher-Pines and Ateev Mehrotra appear in the February 2014 issue…
-
Techniques Boost Range, Accuracy of Wireless ID Signals
Engineers at University of Cambridge in the U.K. developed techniques to vastly improve the range and accuracy of passive radio-frequency identification (RFID) tags used to identify passports, luggage, and goods in transit. The team led by Cambridge research fellow Sabesan Sithamparanathan published its findings online in the journal IEEE Transactions on Antennas and Propagation (paid…
-
Synthetic Bio Platform Finds Potential Superbug Antibiotic
Researchers at University of California in San Diego created a process for cloning synthetic gene clusters from marine bacteria that generate molecules with therapeutic potential, and produced an antibiotic candidate to treat previously drug-resistant infections. The team led by UC-San Diego oceanography and pharmacy professor Bradley Moore, published its findings yesterday online in the journal…
-
Cancer Organizations, Biotech Partner on Drug Discovery
Institute of Cancer Research and Cancer Research Technology in London, and the drug discovery company Nuevolution A/S in Copenhagen, are collaborating on identifying leads for new cancer treatments that act on a promising biological pathway. The agreement includes the option to co-develop therapies from candidates identified in the project, but financial aspects of the deal…
-
Simple, Sensitive Biosensors Derived from Engineered Viruses
Bioengineers at University of California in Berkeley developed a process for making sensors from genetically-engineered viruses simple enough to package in a smartphone app, yet can discriminate among volatile chemical vapors. The team from the lab of bioengineering professor Seung-Wuk Lee, with colleagues from Lawrence Berkeley National Lab — where Lee is also on the…
-
Institutes Developing Power Grid Cybersecurity Technology
Engineering labs at Georgia Institute of Technology in Atlanta are designing a suite of tools to better protect electric power grids, incorporating lessons from recent smart grid developments. The $1.7 million grant from U.S. Department of Energy will fund the work of the Georgia Tech Research Institute, with two other organizations affiliated with Georgia Tech:…
-
Regeneron, Geisinger Health to Partner on Genetic Sequencing
Regeneron Pharmaceuticals Inc. in Tarrytown, New York and Geisinger Health System, a health care provider in Pennsylvania, are studying genetic causes of disease among the 2.6 million residents in areas served by Geisinger’s facilities. Financial terms of the five-year agreement were not disclosed. Under the deal, Geisinger will collect blood specimens from 100,000 Geisinger patients…